This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Ben Goldacre | |
|---|---|
| Name | Ben Goldacre |
| Birth date | 1974 |
| Birth place | London, England |
| Occupation | Physician, academic, science writer |
| Alma mater | University of Oxford, University College London |
| Notable works | Bad Science, Bad Pharma |
Ben Goldacre
Ben Goldacre is a British physician, academic and science writer known for scrutinising pharmaceutical practice, evidence-based medicine and public understanding of science. He has combined clinical roles with investigative journalism and academic research, engaging with institutions across United Kingdom, European Union and international scientific communities. His writing and broadcasting have stimulated debates involving regulators, publishers and policy-makers including National Health Service, European Medicines Agency and major scientific journals.
Goldacre was born in London and educated at St Paul's School, London and studied medicine at Magdalen College, Oxford and clinical training at University College London Medical School. During his student years he engaged with student newspapers and societies at University of Oxford and participated in outreach with organisations such as Wellcome Trust and British Medical Association. He later undertook postgraduate work and research training connected with institutions like Imperial College London and collaborated with teams at University of Oxford and University College London.
Goldacre trained as a doctor within trusts associated with the National Health Service and held clinical posts in psychiatry and primary care linked to Guy's and St Thomas' NHS Foundation Trust and other teaching hospitals. His research interests have included evidence synthesis, clinical trial transparency and pharmacoepidemiology, collaborating with groups at University College London, University of Oxford and international centres such as Harvard Medical School researchers and networks. He has published peer-reviewed work in journals such as The Lancet, BMJ and contributions that intersect with policy bodies including National Institute for Health and Care Excellence and regulatory agencies like the Medicines and Healthcare products Regulatory Agency.
Goldacre launched the "Bad Science" column in The Guardian, critiquing media coverage and commercial claims about health, nutrition and alternative therapies, drawing responses from outlets including BBC, Channel 4, ITV and newspapers such as The Times and The Daily Telegraph. He adapted themes from the column into the book Bad Science, which provoked exchanges with figures from Andrew Wakefield-related controversies to commentators in The Daily Mail and advocates of complementary therapies linked to organisations such as the Prince's Foundation for Integrated Health. His media work extended to documentaries and appearances on programmes like Newsnight and collaborations with broadcasters such as BBC Radio 4 and producers with ties to Open University.
As a public communicator he has engaged with scientific societies including the Royal Society, Royal College of Physicians and Academy of Medical Sciences and participated in debates at venues like The British Library and festivals such as the Hay Festival and Cheltenham Science Festival. Goldacre has campaigned for transparency in clinical trial data alongside groups such as AllTrials and institutions including the World Health Organization and European Medicines Agency, pressing publishers like Elsevier, Springer Nature and the Wiley group to improve data access. He has advised parliamentary committees including the House of Commons Science and Technology Committee and worked with regulators such as the Medicines and Healthcare products Regulatory Agency and the European Commission on policy initiatives.
Goldacre's books Bad Science and Bad Pharma generated debate with pharmaceutical companies including GlaxoSmithKline, Pfizer, Roche and regulatory bodies such as the Food and Drug Administration and European Medicines Agency. He has written extensively in newspapers and journals including The Guardian, The New York Times, The Economist and academic outlets such as BMJ and The Lancet, engaging with scholars from Harvard Medical School, Stanford University, Johns Hopkins University and King's College London. Key controversies involved critiques of data withholding by companies and journals such as The BMJ Publishing Group and disputes involving figures associated with vested interests in alternative medicine, pharmaceutical marketing practices scrutinised by Office of Fair Trading investigations and policy responses from National Institute for Health and Care Excellence and World Health Organization panels.
Goldacre is married and has family connections active in journalism and the arts, with public interactions involving commentators and organisations such as New Scientist and Nature (journal). He has received awards and recognition from bodies including the Medical Journalists' Association, Royal Society events and science communication prizes linked to institutions like Wellcome Trust and British Science Association. He has held fellowships and honorary positions at universities and research centres such as University College London and University of Oxford and contributed to advisory panels convened by groups including the Department of Health and Social Care and international agencies such as the World Health Organization.
Category:British physicians Category:Science communicators